Related Experiment Videos
Otitis externa in the dog -- a clinical and microbiological study
Summary
A topical medication containing Fucidin, Framycetin, Nystatin, and Prednisolone effectively treated canine otitis externa, with 91% of dogs showing clinical improvement. Infections caused by Pseudomonas aeruginosa may require extended treatment.
Area of Science:
- Veterinary Dermatology
- Microbiology
Background:
- Canine otitis externa is a common condition often caused by bacterial and yeast infections.
- Topical antimicrobial and anti-inflammatory preparations are frequently used for treatment.
Purpose of the Study:
- To evaluate the efficacy of a combination topical preparation (Fucidin, Framycetin, Nystatin, Prednisolone) for canine otitis externa.
- To determine the microbiological profile and antibiotic sensitivity patterns in affected canine ears.
Main Methods:
- A clinical trial involving 235 dog ears with otitis externa.
- Exclusion of cases with parasitic or foreign body causes or those requiring systemic therapy.
- Bacteriological examination and antibiotic sensitivity testing of isolates from 434 affected ears.
Main Results:
- Staphylococci plus yeasts were the most frequent isolates (29%), followed by pure yeast (19%) and staphylococcus (16%) infections.
- Neomycin (Framycetin) showed satisfactory in vitro activity against common bacteria, and Fucidin was highly effective against staphylococci.
- Approximately 91% of treated ears achieved clinical cure or considerable improvement.
- Pseudomonas aeruginosa infections presented a treatment challenge.
Conclusions:
- The combination topical preparation demonstrated high clinical efficacy in treating canine otitis externa.
- Antibiotic sensitivity testing guides treatment selection, with Fucidin and Neomycin showing good in vitro effectiveness.
- Extended treatment duration may be necessary for recalcitrant infections, particularly those involving Pseudomonas aeruginosa.